Nov 15, 2017

Opioid addiction treatments are equally effective, study finds

Vivitrol packaging. Photo: Carla K. Johnson / AP

The first study in the U.S. to directly compare two medications to treat opioid addiction — one injected monthly, one given daily as a film placed under the tongue — found the treatments are equally effective, according to research published in the Lancet on Tuesday.

Yes but: Naltrexone (or Vivitrol) injections can't begin until someone has detoxed, typically after a few days. In the study, 28 percent of the participants who were to receive naltrexone didn't detox and couldn't begin the treatment.

What it means: Increasing access to medications for treating opioid addiction was a top recommendation from President Trump's opioid crisis commission. One potential advantage of naltrexone for some patients is that it is a monthly shot versus a daily treatment. Until now, there was limited data about the medication's effectiveness. "We need as many evidence-based options as possible because opioid abuse disorder is more deadly and affecting more people," says Alex Walley, a physician and researcher at Boston Medical Center's Grayken Center for Addiction, who was not involved in the study. He says detox programs should be offering both treatments and allowing patients and their physicians to choose.

What they did: 570 people who had used illegal opioids, mostly heroin, were recruited from inpatient treatment clinics in eight different locations across the U.S. Roughly half of the people in the study received monthly shots of Vivitrol, and the other half took buprenorphine and naloxone (Suboxone) at home each day.

The researchers then tracked any relapses, overdoses, and deaths in the groups over the following 24 weeks. 52 percent of the people that were able to detox and receive naltrexone relapsed during the next six months versus 56 percent of the group that received Suboxone. "We need to think of staying on medication as an important outcome," says Walley.

The big question: What happens long-term? Nora Volkow, director of the National Institute on Drug Abuse, which funded the trial, says they want to understand the characteristics of patients that determine if they will respond better to one treatment versus another. They also want to know how protocols used by centers to initiate treatments might be standardized and improved.

Editor's note: This story has been corrected. In the study, Suboxone was administered daily as a film placed under the tongue, not a pill.

Go deeper

South Korea and Italy step up measures as coronavirus cases spike

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

The novel coronavirus has spread to more nations as South Korea and Italy in particular scramble to deal with spikes in their countries.

The big picture: COVID-19 has killed at least 2,446 people and infected almost 79,000 others, mostly in mainland China. South Korean President Moon Jae-said country would increase its infectious disease alert to red, the highest level possible, the New York Times reports, as the number of cases in the country soared to 556 and the death toll to five. Italy's government announced emergency measures Sunday after infections rose to 79.

Go deeperArrowUpdated 16 mins ago - Health

Bernie Sanders wins Nevada caucus

Democratic presidential candidate Sen. Bernie Sanders waves to supporters at a campaign rally on Friday in Las Vegas. Photo: Mario Tama/Getty Images

Sen. Bernie Sanders is projected to handily win the Nevada Democratic primary caucus, becoming the clear frontrunner among 2020 Democratic presidential primary election candidates.

Why it matters: Nevada is the first state with a diverse population to hold a nominating contest, highlighting candidates' abilities to connect with voters of color — particularly Latino voters.

Go deeperArrowUpdated 42 mins ago - Politics & Policy

Heat wave melts 20% of snow cover from Antarctic island in days

The effects of February's record heat wave on Eagle Island in Antarctica. Photo: NASA

Antarctica's Eagle Island now has a side that's almost ice-free following this month's searing heat wave in the region, images released by NASA show.

Why it maters: "The warm spell caused widespread melting on nearby glaciers," NASA said in its report. It's the third major melt event of the 2019-2020 Southern Hemisphere summer, following warm spells in January and last November, according to the United Nation's World Meteorological Organization (WMO).